Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:48 AM
Ignite Modification Date:
2025-12-25 @ 4:48 AM
NCT ID:
NCT00851318
Eligibility Criteria:
Inclusion Criteria:
* Subjects who participated in Study 275-08-001 and meet all of the criteria described below.
* Patients who did not reach ACR20, and prematurely discontinued Study 275-08-001 at Week 16 or completed Study 275-08-001 by Week 24.
* Patients who are able to receive treatment with MTX, by Week 52.
Exclusion Criteria:
* Patients who experienced an important protocol deviation as mentioned below during Study 275-08-001.
* Patients who received live or attenuated vaccines during Study 275-08-001(Except for influenza or pneumococcal vaccines).
* Patients who were found to have tuberculosis on a chest X-ray during Study 275-08-001.
* Patients who required treatment for the same infection at two or more different times during Study 275-08-001
* Women who are pregnant, are lactating, of childbearing potential and wish to conceive during the study and post-study 3 months.
* Patients whom the investigator has decided to be inappropriate for participation in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
74 Years
Study:
NCT00851318
Study Brief:
Protocol Section:
NCT00851318